Treatment of viral infections using prodrugs of...

Details Treatment of viral infections using prodrugs of... Treatment of viral infections using prodrugs of...

2005-12-13

2005-12-13

Wilson, James O. (Department: 1623)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

C514S048000, C536S027140, C536S028100, C536S028200

Reexamination Certificate

active

06974802

ABSTRACT:
A method of treating HBV or HIV infections comprising administering to an individual an effective amount of the compound of formula IId′:wherein R2is the residue of an aliphatic L-amino acid, p is 0, 1, or 2-20, and q is 0, or a pharmaceutically acceptable salt thereof.

REFERENCES:
patent: 3705191 (1972-12-01), Kerst
patent: 4168267 (1979-09-01), Petrillo, Jr.
patent: 4309364 (1982-01-01), Bentzen et al.
patent: 4337201 (1982-06-01), Petrillo, Jr.
patent: 4486425 (1984-12-01), Nakao et al.
patent: 4594199 (1986-06-01), Thottathil
patent: 4760057 (1988-07-01), Alexander
patent: 4942157 (1990-07-01), Gall et al.
patent: 4957924 (1990-09-01), Beauchamp
patent: 4963662 (1990-10-01), Matthes et al.
patent: 5001115 (1991-03-01), Sloan
patent: 5073641 (1991-12-01), Bundgaard et al.
patent: 5198539 (1993-03-01), Rahim et al.
patent: 5227506 (1993-07-01), Saari et al.
patent: 5376649 (1994-12-01), Pohjala et al.
patent: 5441942 (1995-08-01), Goodman et al.
patent: 5466811 (1995-11-01), Alexander
patent: 5484911 (1996-01-01), Hong et al.
patent: 5543414 (1996-08-01), Nestor et al.
patent: 5618804 (1997-04-01), Kawabe et al.
patent: 5624897 (1997-04-01), Jeschke et al.
patent: 5624917 (1997-04-01), Kitano et al.
patent: 5717095 (1998-02-01), Arimilli et al.
patent: 6458772 (2002-10-01), Zhou et al.
patent: 2002/0142969 (2002-10-01), Jeschke et al.
patent: 2112057 (1971-09-01), None
patent: 195 29 604 (1995-05-01), None
patent: 176 217 (1986-04-01), None
patent: 372 268 (1990-06-01), None
patent: 0375329 (1990-06-01), None
patent: 658 551 (1995-06-01), None
patent: 0694547 (1996-01-01), None
patent: WO 91/06554 (1991-05-01), None
patent: 05-229997 (1993-09-01), None
patent: WO8800050 (1988-01-01), None
patent: WO8903837 (1989-05-01), None
patent: WO9008128 (1990-07-01), None
patent: WO9008155 (1990-07-01), None
patent: WO9119721 (1991-12-01), None
patent: WO9200988 (1992-01-01), None
patent: WO9213561 (1992-08-01), None
patent: WO9413324 (1994-06-01), None
patent: WO9424134 (1994-10-01), None
patent: WO9501363 (1995-01-01), None
patent: WO9512604 (1995-05-01), None
patent: WO9512605 (1995-05-01), None
patent: WO9514016 (1995-05-01), None
patent: WO9532984 (1995-12-01), None
patent: WO9615132 (1996-05-01), None
patent: WO9621440 (1996-07-01), None
patent: WO9622303 (1996-07-01), None
patent: WO9631227 (1996-10-01), None
patent: WO9633201 (1996-10-01), None
patent: WO9705154 (1997-02-01), None
patent: WO9727194 (1997-07-01), None
patent: WO9730051 (1997-08-01), None
patent: WO9821223 (1998-05-01), None
patent: WO9846576 (1998-10-01), None
patent: WO9851692 (1998-11-01), None
Tetrehedron Letters, 30(51) 1989, 7141-44, Iyer, R et al “Synthesis of Acyloxyalkyl Acylphosphonates . . . ”.
J Med Chem 39(1) 1996, 10-18, Robinson, R et al “Discovery of the Hemifumarate and . . . ”.
International J of Pharmaceutics 104 (1994) 157-67, Walker, I et al. “Drug delivery via active transport at the blood-brain barrier: affinity . . . ”.
Abstract of WO 98/11126, Sep. 9, 1997, Larsen, B et al. “Peptide prodrugs containing an alpha-hydroxyacid linker”.
Meziane-Cherif, D. et al., “Purification and characterization of the VanB . . . ,” FEBS Letters 354 (1994) pp. 141-142.
Ohyama, M. et al., “Total Synthesis of the Anthelmintic . . . ,” Biosci. Biotech. Biochem. (1994), 58(6), pp. 1193-1194.
Wu, Z. et al., “Overexpression, Purification, and Characterization . . . ,” Biochemistry (1995), 34, pp. 2455-2463.
Nyeki, O. et al., “Synthesis of Angiotensin II . . . ,” J. Med. Chem. (1987), 30, pp. 1719-1724.
Kigasawa, K. et al., “Decomposition and Stabilization of Drugs . . . ,” Yakugaku Zasshi (1979), 99, pp. 402-412.
Schacht, E. et al., “Biomedical Applications of Degradable . . . ,” Biotechnology and Bioengineering (1996), 52, pp. 102-108.

Affiliated with

Also associated with

Rating

Treatment of viral infections using prodrugs of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of viral infections using prodrugs of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of viral infections using prodrugs of... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3473958